The multiplex MBA-Magpix technology assay provides an accurate high throughput monitoring of parasite-specific antibodies during symptomatic malaria.
Organisation: In2Care BV, The Netherlands
This study demonstrates the non-inferiority of AS+AQ versus AL, its efficacy and tolerance in the management of uncomplicated Plasmodium falciparum malaria in African children.
This work confirms the presence of the two species in the same country for the first time, in the Ivory Coast and the Comoros Islands.
The increased spread of drug-resistant malaria highlights the need for alternative drugs for treatment and chemoprophylaxis.
Plasmodium ovale malaria is currently a problem to diagnose in travellers, notably in French soldiers returning from the Ivory Coast.
This study demonstrates the efficacy and tolerability of AS + AQ for uncomplicated Plasmodium falciparum malaria treatment in African patients over the age of 7 years.
Raphael N’Guessan is a Medical Entomologist and West Africa IVCC programme manager based in Benin. His current research interests are on malaria vector control, with particular emphasis on control of resistant vectors, insecticide resistance management, and investigation of alternative strategies for its delay.
Q: Dear Raphael, please tell us what the main focus of your work is, and why this is important within the framework of malaria control and elimination.
In this study, we aimed to assess the effect of iron fortification, intermittent preventive treatment (IPT) of malaria, and anthelmintic treatment on hemoglobin concentration and anemia prevalence among school children.
The objective of this study was to identify demographic, environmental and socioeconomic risk factors and spatial patterns of Plasmodium falciparum parasitaemia in a high endemicity area of Africa, and to specify how this information can facilitate improved malaria control at the district level.
